Condition
Gut Inflammation
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 1 (1)
P 4 (1)
Trial Status
Completed4
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07253155Not ApplicableEnrolling By InvitationPrimary
Probiotics Use and Preventing Gastrointestinal Symptoms in People Living With Overweight and Obesity.
NCT04497727CompletedPrimary
Gut Organoid and Microbiome Interactions in Hypertension
NCT03399903Phase 1Completed
Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection
NCT02118402Not ApplicableCompleted
Iron and Prebiotics Fortification in Kenyan Infants
NCT03081845Phase 4CompletedPrimary
A1 Versus A2® Milk on the Gastrointestinal Physiology, Symptoms and Cognitive Behaviour for the Preschool Children
Showing all 5 trials